Company Filing History:
Years Active: 1986-1988
Title: Yves Berger: Innovator in Pharmaceutical Compositions
Introduction
Yves Berger is a notable inventor based in Wemmel, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating ischemic conditions. With a total of 3 patents to his name, Berger's work has the potential to impact both human and veterinary medicine.
Latest Patents
Berger's latest patents focus on pharmaceutical and veterinary compositions that utilize benzofuran derivatives. These compositions are designed to treat ischemic cardiac disorders. The active ingredients include at least one benzofuran derivative, which can be combined with pharmaceutically acceptable acid addition salts. The specific formulations are aimed at providing effective treatment options for ischemic conditions.
Career Highlights
Yves Berger has been associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to explore innovative solutions in the pharmaceutical industry. His dedication to research and development has led to advancements in the treatment of ischemic disorders.
Collaborations
Berger has collaborated with Marcel Descamps, contributing to the development of new pharmaceutical compositions. Their partnership has fostered innovation and has been instrumental in advancing their research efforts.
Conclusion
Yves Berger's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare outcomes. His patents reflect a deep understanding of the complexities involved in treating ischemic conditions. Through his work, he continues to pave the way for future advancements in medicine.